These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 23929771)

  • 1. The pathogenesis of lupus nephritis.
    Lech M; Anders HJ
    J Am Soc Nephrol; 2013 Sep; 24(9):1357-66. PubMed ID: 23929771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophils, Dendritic Cells, Toll-Like Receptors, and Interferon-α in Lupus Nephritis.
    Lorenz G; Anders HJ
    Semin Nephrol; 2015 Sep; 35(5):410-26. PubMed ID: 26573544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus nephritis: from pathogenesis to targets for biologic treatment.
    Liu Y; Anders HJ
    Nephron Clin Pract; 2014; 128(3-4):224-31. PubMed ID: 25401461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus nephritis: update on mechanisms of systemic autoimmunity and kidney immunopathology.
    Lorenz G; Desai J; Anders HJ
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):211-7. PubMed ID: 24662982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus nephritis. How latest insights into its pathogenesis promote novel therapies.
    Kulkarni OP; Anders HJ
    Curr Opin Rheumatol; 2012 Sep; 24(5):457-65. PubMed ID: 22810362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of kidney disease in systemic lupus erythematosus.
    Bagavant H; Fu SM
    Curr Opin Rheumatol; 2009 Sep; 21(5):489-94. PubMed ID: 19584729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be.
    Rekvig OP
    Front Immunol; 2019; 10():1104. PubMed ID: 31156647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity against nucleosomes and lupus nephritis.
    Van Bruggen MC; Kramers C; Berden JH
    Ann Med Interne (Paris); 1996; 147(7):485-9. PubMed ID: 9092359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved.
    Rekvig OP; Van der Vlag J
    Semin Immunopathol; 2014 May; 36(3):301-11. PubMed ID: 24763531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors in lupus nephritis.
    Devarapu SK; Anders HJ
    J Biomed Sci; 2018 Apr; 25(1):35. PubMed ID: 29650017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor activation in the pathogenesis of lupus nephritis.
    Lorenz G; Lech M; Anders HJ
    Clin Immunol; 2017 Dec; 185():86-94. PubMed ID: 27423476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus nephritis: role of antinucleosome autoantibodies.
    van der Vlag J; Berden JH
    Semin Nephrol; 2011 Jul; 31(4):376-89. PubMed ID: 21839371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic autoantibodies in lupus nephritis.
    Waldman M; Madaio MP
    Lupus; 2005; 14(1):19-24. PubMed ID: 15732283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis.
    Pawar RD; Patole PS; Ellwart A; Lech M; Segerer S; Schlondorff D; Anders HJ
    J Am Soc Nephrol; 2006 Dec; 17(12):3365-73. PubMed ID: 17082246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of renal involvement in patients with systemic lupus erythematosus.
    Satirapoj B; Wongchinsri J; Youngprang N; Laonapaporn B; Chitrada T; Lapkittichareonchai S; Patumanon J
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):17-25. PubMed ID: 17891918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus.
    Teichmann LL; Schenten D; Medzhitov R; Kashgarian M; Shlomchik MJ
    Immunity; 2013 Mar; 38(3):528-40. PubMed ID: 23499488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus nephritis in a pediatric renal transplant recipient.
    Fox L; Zager PG; Harford AM; Tung KS; Smith SM
    Pediatr Nephrol; 1992 Sep; 6(5):467-9. PubMed ID: 1457330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
    Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
    Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue fever evolving into systemic lupus erythematosus and lupus nephritis: a case report.
    Rajadhyaksha A; Mehra S
    Lupus; 2012 Aug; 21(9):999-1002. PubMed ID: 22354536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.